Evidence map›Paper›PMID 33922041›Full record

ArticleInternational journal of molecular sciences2021

Characterization of Long Non-Coding RNAs in Systemic Sclerosis Monocytes: A Potential Role for PSMB8-AS1 in Altered Cytokine Secretion.

Nila H Servaas, Barbara Mariotti, Maarten van der Kroef, Catharina G K Wichers, Aridaman Pandit, Flavia Bazzoni, Timothy R D J Radstake, Marzia Rossato

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Epigenetic Dysregulation in Autoimmune and Inflammatory Skin Diseases.Clinical reviews in allergy & immunology · 2022
    Review
  6. Novel role of long non-coding RNAs in autoimmune cutaneous disease.Journal of cell communication and signaling · 2022
    Review
  7. Review
  8. Article
  9. Review
  10. Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis.International journal of general medicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Nila H ServaasCenter for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Barbara MariottiDivision of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy.ORCID 0000-0001-5831-8319
Maarten van der KroefCenter for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Catharina G K WichersCenter for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Aridaman PanditCenter for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.ORCID 0000-0003-2057-9737
Flavia BazzoniDivision of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy.
Timothy R D J RadstakeCenter for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Marzia RossatoDepartment of Biotechnology, University of Verona, 37134 Verona, Italy.
Utrecht University · NLUniversity of Verona · IT

Funding

Ateneo di Verona, Progetti di Ricerca di Interesse Nazionale PRIN2017, Prot. 20174T7NXLERC starting grant ERC-2011-StG, Circum-ventFondazione CARIPLO 2015-0584IEF Marie Curie fellowship 622811, MicroSCAPJoint project 2017 JPVR2017
6 · The paper itself

Abstract

Systemic sclerosis (SSc) is a chronic autoimmune disease mainly affecting the connective tissue. In SSc patients, monocytes are increased in circulation, infiltrate affected tissues, and show a pro-inflammatory activation status, including the so-called interferon (IFN) signature. We previously demonstrated that the dysregulation of the IFN response in SSc monocytes is sustained by altered epigenetic factors as well as by upregulation of the long non-coding RNA (lncRNA) NRIR. Considering the enormously diverse molecular functions of lncRNAs in immune regulation, the present study investigated the genome-wide profile of lncRNAs in SSc monocytes, with the aim to further unravel their possible role in monocyte dysregulation and disease pathogenesis. Transcriptomic data from two independent cohorts of SSc patients identified 886 lncRNAs with an altered expression in SSc monocytes. Differentially expressed lncRNAs were correlated with neighboring protein coding genes implicated in the regulation of IFN responses and apoptotic signaling in SSc monocytes. In parallel, gene co-expression network analysis identified the lncRNA PSMB8-AS1 as a top-ranking hub gene in co-expression modules implicated in cell activation and response to viral and external stimuli. Functional characterization of PSMB8-AS1 in monocytes demonstrated that this lncRNA is involved in the secretion of IL-6 and TNFα, two pivotal pro-inflammatory cytokines altered in the circulation of SSc patients and associated with fibrosis and disease severity. Collectively, our data showed that lncRNAs are linked to monocyte dysregulation in SSc, and highlight their potential contribution to disease pathogenesis.

Indexed as

AdultAgedCase-Control StudiesCytokinesFemaleHumansMaleMiddle AgedMonocytesProteasome Endopeptidase ComplexRNA, AntisenseRNA, Long NoncodingScleroderma, SystemicTranscriptomeCytokinesLMP7 proteinProteasome Endopeptidase ComplexRNA, AntisenseRNA, Long Noncodingautoimmuneco-expression networklong non-coding RNAmonocytessystemic sclerosis

Identifiers

PMID33922041
PMCPMC8122435
OpenAlexW3159224634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.